<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02073409</url>
  </required_header>
  <id_info>
    <org_study_id>NTM-OB-17 (PREDICT PART A)</org_study_id>
    <nct_id>NCT02073409</nct_id>
  </id_info>
  <brief_title>PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis</brief_title>
  <acronym>PREDICT</acronym>
  <official_title>Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Jewish Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cystic Fibrosis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Colorado</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Jewish Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Isolation of nontuberculous mycobacteria (NTM) from the sputum of individuals with CF is an&#xD;
      increasingly common finding, and the lack of an evidenced-based approach to the diagnosis of&#xD;
      NTM disease has been identified as one of the greatest unmet needs within the CF community.&#xD;
      Current evidence predicts that the prevalence of NTM will remain relatively high in the CF&#xD;
      population. Approaches to NTM disease diagnosis differ widely between centers. This study is&#xD;
      observational and follows current best practices. The study will help standardize the&#xD;
      diagnosis and collect relevant data associated with the diagnosis of NTM disease to build a&#xD;
      framework for future therapeutic trials.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion meeting the diagnosis of NTM disease</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adherence to PREDICT protocol: number of respiratory cultures obtained per participant per year, withdrawals and major deviations from protocol</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and prevalence of NTM species/subspecies by geographical region</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of eligible NTM positive individuals with CF enrolling in PREDICT by site</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of PREDICT participants with NTM disease diagnosis who enroll in Part B PATIENCE</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical parameters and outcomes (FEV1, growth parameters, CFQ-R)</measure>
    <time_frame>12 months intervals following study enrollment</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>CF patients</arm_group_label>
    <description>Male and female subjects with CF age 6 years and older who have a positive sputum culture for NTM.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples collected may include serum, sputum, whole blood, breath, urine, and NTM isolates.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female subjects with CF age 6 years and older who have a positive sputum culture&#xD;
        for NTM.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Written informed consent (and assent when applicable) obtained from participant or&#xD;
             participant's legal representative&#xD;
&#xD;
          2. Enrolled in the CFF Patient Registry (CFF PR)&#xD;
&#xD;
          3. Be willing and able to adhere to study procedures in the context of clinical care, and&#xD;
             other protocol requirements&#xD;
&#xD;
          4. Male or female participant â‰¥ 6 years of age at enrollment who are able to reliably&#xD;
             expectorate sputum and/or willing to undergo sputum induction (if necessary)&#xD;
&#xD;
          5. Diagnosis of CF consistent with the 2017 CFF Guidelines&#xD;
&#xD;
          6. NTM positive for a species or sub-species in the 2 years prior to enrollment that has&#xD;
             never been treated.&#xD;
&#xD;
          7. Willing to discontinue chronic azithromycin use for the duration of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Prior or ongoing antibiotic treatment of the same NTM species or sub-species for which&#xD;
             the patient is being considered for this study&#xD;
&#xD;
          2. History of solid organ or hematological transplantation&#xD;
&#xD;
          3. Has any other condition that, in the opinion of the Site Investigator/designee, would&#xD;
             preclude informed consent or assent, make study participation unsafe, complicate&#xD;
             interpretation of study outcome data, or otherwise interfere with achieving the study&#xD;
             objectives&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry A Nick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Jewish Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stacey Martiniano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Colorado</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Lovell, RN</last_name>
    <phone>(303) 398-1265</phone>
    <email>lovellv@njhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer Sanchez</last_name>
    <phone>(720) 777-4949</phone>
    <email>jennifer.sanchez@childrenscolorado.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CFF Pediatric Program, University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Hawthorne</last_name>
      <phone>205-638-9568</phone>
      <email>hhathorne@peds.uab.edu</email>
    </contact>
    <investigator>
      <last_name>George M Solomon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Reyes</last_name>
      <phone>323-361-2662</phone>
      <email>mareyes@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Keens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Mielke</last_name>
      <phone>619-471-0822</phone>
      <email>jmielke@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Douglas Conrad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Sanchez, MSW</last_name>
      <phone>720-777-4949</phone>
      <email>Jennifer.Sanchez@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Stacey Martiniano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Lovell, RN</last_name>
      <phone>303-270-2333</phone>
      <email>lovellv@njhealth.org</email>
    </contact>
    <investigator>
      <last_name>Jerry A Nick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noni Graham</last_name>
      <phone>352-294-5195</phone>
      <email>noni.graham@medicine.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Jorge Lascano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Nelson</last_name>
      <phone>312-695-0415</phone>
      <email>rachel.nelson@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Manu Jain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tulane University</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Rockwell</last_name>
      <phone>504-988-2325</phone>
      <email>crockwell@tulane.edu</email>
    </contact>
    <investigator>
      <last_name>Ross Klingsberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Adult Program, Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Britany Zeglin</last_name>
      <phone>443-287-8983</phone>
      <email>bzeglin1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Keira Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital, Brigham &amp; Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Fowler</last_name>
      <phone>617-355-1834</phone>
      <email>robert.fowler@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Rebecca Cagnina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Pediatric Program University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Kruse</last_name>
      <phone>734-615-3266</phone>
      <email>dmkruse@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Lindsay Caverly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Rodgers</last_name>
      <phone>603-650-9718</phone>
    </contact>
    <investigator>
      <last_name>Brian O'Sullivan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Pediatric Program, Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Liriano</last_name>
      <phone>215-305-4675</phone>
      <email>crl58@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Emily DiMango, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Adult Program, University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27517</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margret Powell</last_name>
      <phone>919-445-2855</phone>
      <email>margret_powell@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Goralski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Gilmore</last_name>
      <phone>614-722-4752</phone>
      <email>diana.gilmore@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Karen McCoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Hartigan</last_name>
      <phone>412-692-7060</phone>
      <email>elizabeth.hartigan@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Pilewski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Adult Program, The University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-8558</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Keller</last_name>
      <phone>214-648-2817</phone>
      <email>Ashley.Keller@UTSouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Raksha Jain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Vermont Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Sweet</last_name>
      <phone>802-847-7958</phone>
      <email>julie.sweet@uvmhealth.org</email>
    </contact>
    <investigator>
      <last_name>Zachary Weintraub, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Pediatric Program Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon McNamara</last_name>
      <phone>206-987-3921</phone>
      <email>sharon.mcnamara@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Ronald Gibson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CFF Adult Program, University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Gambol</last_name>
      <phone>206-543-7382</phone>
      <email>TGambol@medicine.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Moira Aitken, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 24, 2014</study_first_submitted>
  <study_first_submitted_qc>February 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2014</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Jewish Health</investigator_affiliation>
    <investigator_full_name>Jerry A. Nick, M.D.</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Nontuberculous Mycobacteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

